Immatics (IMTX) Enterprise Value (2019 - 2025)
Immatics (IMTX) reported Enterprise Value of -$546.3 million for Q4 2025, up 15.42% on a YoY basis from -$473.3 million in Q4 2024, and down 8.47% sequentially from -$503.7 million in Q3 2025.
Immatics (IMTX) Enterprise Value (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Enterprise Value data on file, last reported at -$546.3 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 15.42% year-over-year to -$546.3 million; the trailing twelve-month figure through Dec 2025 stood at -$546.3 million (up 15.42% YoY), and the FY2025 full-year result was -$530.3 million, up 18.95% from the prior year.
- Enterprise Value fell to -$546.3 million in Q4 2025, from -$503.7 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$166.0 million in Q4 2021 to a low of -$645.9 million in Q4 2024.
- A 5-year average of -$415.8 million and a median of -$398.4 million in 2023 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 39.98% in 2021, while the deepest fall reached 146.41% in 2021.
- Tracing IMTX's Enterprise Value over 5 years: stood at -$166.0 million in 2021, then slumped by 122.6% to -$369.5 million in 2022, then dropped by 24.0% to -$458.2 million in 2023, then tumbled by 40.96% to -$645.9 million in 2024, then advanced by 15.42% to -$546.3 million in 2025.
- Business Quant data shows IMTX's Enterprise Value at -$546.3 million in Q4 2025, -$503.7 million in Q3 2025, and -$541.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | -546.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -546.33 Mn |
| Sep 30, 2025 | -503.67 Mn |
| Jun 30, 2025 | -541.29 Mn |
| Mar 31, 2025 | -571.97 Mn |
| Dec 31, 2024 | -645.91 Mn |
| Sep 30, 2024 | -538.70 Mn |
| Jun 30, 2024 | -571.94 Mn |
| Mar 31, 2024 | -612.65 Mn |
| Dec 31, 2023 | -458.24 Mn |
| Sep 30, 2023 | -398.45 Mn |
| Jun 30, 2023 | -398.26 Mn |
| Mar 31, 2023 | -354.00 Mn |
| Dec 31, 2022 | -369.54 Mn |
| Sep 30, 2022 | -311.89 Mn |
| Jun 30, 2022 | -346.13 Mn |
| Mar 31, 2022 | -283.66 Mn |
| Dec 31, 2021 | -166.01 Mn |
| Sep 30, 2021 | -204.27 Mn |
| Jun 30, 2021 | -232.19 Mn |
| Mar 31, 2021 | -261.34 Mn |